Literature DB >> 26285470

[DIABETIC NEPHROPATHY AS A CAUSE OF CHRONIC KIDNEY DISEASE].

Ivan Kos, Ingrid Prkačin.   

Abstract

Diabetic nephropathy is the leading cause of end-stage chronic kidney disease in most developed countries. Hyperglycemia, hypertension and genetic predisposition are the main risk factors for the development of diabetic nephropathy. Elevated serum lipids, smoking habits, and the amount and origin of dietary protein also seem to play a role as risk factors. Clinical picture includes a progressive increase in albuminuria, decline in glomerular filtration, hypertension, and a high risk of cardiovascular morbidity and mortality. Screening for albuminuria should be performed yearly, starting 5 years after diagnosis in type 1 diabetes or earlier in the presence of adolescence or poor metabolic control. In patients with type 2 diabetes, screening should be performed at diagnosis and yearly thereafter. Patients with albuminuria should undergo evaluation regarding the presence of associated comorbidities, especially retinopathy and macrovascular disease. Achieving the best metabolic control (HbA1c < 7%), treating hypertension (target blood pressure < 140/85 mm Hg), using drugs with blockade effect on the renin-angiotensin-aldosterone system, treating dyslipidemia and anemia are effective strategies for preventing the development of albuminuria, delaying the progression to more advanced stages of nephropathy and reducing cardiovascular mortality in patients with type 1 and type 2 diabetes.

Entities:  

Mesh:

Year:  2014        PMID: 26285470

Source DB:  PubMed          Journal:  Acta Med Croatica        ISSN: 1330-0164


  5 in total

1.  In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes.

Authors:  Arjun Jain; Vidhi Mehrotra; Ira Jha; Ashok Jain
Journal:  J Diabetes Metab Disord       Date:  2019-04-08

2.  Transcription factor 7-like 2 gene- smoking interaction on the risk of diabetic nephropathy in Chinese Han population.

Authors:  Peng Xue; Haihong Cao; Zhimin Ma; Ying Zhou; Nian Wang
Journal:  Genes Environ       Date:  2021-06-30

3.  Associations of TCF7L2 gene polymorphisms with the risk of diabetic nephropathy: A case-control study.

Authors:  Yan Zhuang; Fukun Niu; Defeng Liu; Juanjuan Sun; Xiaowei Zhang; Jian Zhang; Shuxia Guo
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  Interaction between ELMO1 gene polymorphisms and environment factors on susceptibility to diabetic nephropathy in Chinese Han population.

Authors:  Yi Hou; Yong Gao; Yan Zhang; Si-Tong Lin; Yue Yu; Liu Yang
Journal:  Diabetol Metab Syndr       Date:  2019-11-27       Impact factor: 3.320

5.  Antioxidant effect of endothelin-1 receptor antagonist protects the rat kidney against chronic injury induced by hypertension and hyperglycemia.

Authors:  Agnaldo Caires; Marcia Bastos Convento; Bianca Castino; Ala Moana Leme; Edson de Andrade Pessoa; Alef Aragão; Nestor Schor; Fernanda Teixeira Borges
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.